Literature DB >> 21041501

Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania.

Guo-Bao Tian1, Jennifer M Adams-Haduch, Tatiana Bogdanovich, Anthony W Pasculle, John P Quinn, Hong-Ning Wang, Yohei Doi.   

Abstract

Three Acinetobacter baumannii isolates that possess OXA-40 group carbapenemase genes were identified. They belonged to novel sequence types (ST122, ST123, and ST124) and harbored bla(OXA-160), bla(OXA-72), and bla(OXA-40), respectively. OXA-160 is a novel variant of OXA-40 with a P227S substitution. An isogenic Escherichia coli clone producing OXA-160 was more susceptible to carbapenems than a clone producing OXA-40. The genetic environment of bla(OXA-160) and bla(OXA-40) beyond the putative XerC/XerD recombination sites was distinct from the scaffold reported previously.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21041501      PMCID： PMC3019651          DOI： 10.1128/AAC.01155-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme.

Authors:  A Di Popolo; M Giannouli; M Triassi; S Brisse; R Zarrilli
Journal:  Clin Microbiol Infect       Date:  2011-02       Impact factor: 8.067

2.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Audrey Wanger; Mark Kruzel; Lalitagauri M Deshpande; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2008-09       Impact factor: 5.948

4.  Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.

Authors:  Elena Santillana; Alejandro Beceiro; Germán Bou; Antonio Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

5.  Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.

Authors:  Sergio G Bartual; Harald Seifert; Corinna Hippler; M Angeles Domínguez Luzon; Hilmar Wisplinghoff; Francisco Rodríguez-Valera
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 6.  OXA-type beta-lactamases.

Authors:  T Naas; P Nordmann
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

7.  Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.

Authors:  Po-Liang Lu; Michel Doumith; David M Livermore; Tyen-Po Chen; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2009-01-31       Impact factor: 5.790

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.

Authors:  Jennifer M Adams-Haduch; David L Paterson; Hanna E Sidjabat; Anthony W Pasculle; Brian A Potoski; Carlene A Muto; Lee H Harrison; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

10.  Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.

Authors:  Hui Wang; Ping Guo; Hongli Sun; He Wang; Qiwen Yang; Minjun Chen; Yingchun Xu; Yuanjue Zhu
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191
View more
  18 in total

1.  First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Authors:  Maria Camila Montealegre; Juan José Maya; Adriana Correa; Paula Espinal; Maria F Mojica; Sory J Ruiz; Fernando Rosso; Jordi Vila; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Sandrine Bernabeu; Lélia Escaut; Daniel Vittecoq; Delphine Girlich; Dilek Imanci; Nicolas Fortineau; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.

Authors:  Thomas M Harper; Cynthia M June; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Biochem J       Date:  2018-01-11       Impact factor: 3.857

4.  Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.

Authors:  Jennifer M Adams-Haduch; Ezenwa O Onuoha; Tatiana Bogdanovich; Guo-Bao Tian; Jonas Marschall; Carl M Urban; Brad J Spellberg; Diane Rhee; Diane C Halstead; Anthony W Pasculle; Yohei Doi
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

5.  Carbapenem-associated multidrug-resistant Acinetobacter baumannii are sensitised by aztreonam in combination with polyamines.

Authors:  Louis Malone; Dong H Kwon
Journal:  Int J Antimicrob Agents       Date:  2012-11-11       Impact factor: 5.283

6.  NDM-1-Producing Citrobacter freundii, Escherichia coli, and Acinetobacter baumannii Identified from a Single Patient in China.

Authors:  Ying-Min Huang; Lan-Lan Zhong; Xue-Fei Zhang; Hang-Tong Hu; Yu-Qi Li; Xiao-Rong Yang; Lian-Qiang Feng; Xi Huang; Guo-Bao Tian
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

7.  Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumannii.

Authors:  Joshua M Mitchell; Jozlyn R Clasman; Cynthia M June; Kip-Chumba J Kaitany; James R LaFleur; Magdalena A Taracila; Neil V Klinger; Robert A Bonomo; Troy Wymore; Agnieszka Szarecka; Rachel A Powers; David A Leonard
Journal:  Biochemistry       Date:  2015-03-02       Impact factor: 3.162

8.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.

Authors:  Margaret A Fitzpatrick; Egon Ozer; Maureen K Bolon; Alan R Hauser
Journal:  J Infect       Date:  2014-09-19       Impact factor: 6.072

Review 10.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.